Similarly, research on GATA6 has revealed its oncogenic role in non-small cell lung cancer (NSCLC) by reducing cell autophagy and cell viability in the H1650 cell line, while in lung cancer it inhibits cell growth in vitro and tumorigenesis in vivo [55,56]. Here, GATA6 is linked to lung carcinoma.